会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明专利
    • Galactose derivative
    • GALACTOSE DERIVATIVE
    • JPS6112697A
    • 1986-01-21
    • JP13388284
    • 1984-06-28
    • Kanto Ishi Pharma Co LtdRikagaku Kenkyusho
    • OGAWA TOMOYASUGIMOTO MAMORUSHIDORI YOSHIYASUITOU MASAYOSHI
    • C07H15/18C07H5/06C07H15/00C07H15/10
    • NEW MATERIAL:A compound shown by the formula I [R
      2 is H, or benzyl, when R
      1 is benzyl; R
      2 is H, acetyl, or benzyl when R
      1 is group shown by the formula II(R
      3 and R
      4 are H or linked to form isopropylidene; R
      5 is benzyl, or allyl; R
      6 is H, acetyl, or benzyl)].
      USE: Useful for synthesizing various gangliosides suitable as a differentiation marker of cell.
      PREPARATION: For example, a galactose derivative of the aimed compound is synthesized from D-lactose octaacetate (1) (OAC group) corresponding to the reaction equations (OBn group), to give compounds shown by the formula (8) and formula (9).
      COPYRIGHT: (C)1986,JPO&Japio
    • 新材料:由式I表示的化合物[R 2为H或苄基,当R 1为苄基时) 当R 1为式II所示基团时,R 2为H,乙酰基或苄基(R 3和R 4为H或连接形成异亚丙基; R 5为苄基或烯丙基; R 6为H,乙酰基或苄基)]。 用途:用于合成适合作为细胞分化标志物的各种神经节苷脂。 制备:例如,由对应于反应式(OBn组)的D-乳糖八乙酸酯(1)(OAC基)合成目标化合物的半乳糖衍生物,得到式(8)和式(9)所示的化合物 )。
    • 6. 发明专利
    • Sialic acid derivative and its preparation
    • 酸性衍生物及其制备方法
    • JPS60190787A
    • 1985-09-28
    • JP4490584
    • 1984-03-09
    • Kanto Ishi Pharma Co LtdRikagaku Kenkyusho
    • OGAWA TOMOYAFUJIKURA KAZUSHIGESUGIMOTO MAMORUSHIDORI YOSHIYASUITOU MASAYOSHI
    • C07H15/10A61K31/70A61K31/7028A61P31/04C07H15/04C07H15/18
    • Y02P20/55
    • NEW MATERIAL:A compound shown by the formula I (R
      1 is H, or CH
      3 ; R
      2 is acyl, or n-propyl; R
      3 and R
      4 are H, D-glucopyranosyl, 2,3,4-tri-O-benzyl-D-glycopyranosyl, 2,3,4-tri-O-benzyl-6-O-monochloroacetyl-D-glucopyranosyl, benzoyl, or benzyl; R
      5 and R
      6 are linked to form isopropylidene, or benzylidene; Ac is acetyl).
      USE: A remedy for meningitis.
      PREPARATION: A compound shown by the formula II is deacetylated, reacted with 2,2-dimethoxypropane to give a novel compound shown by formula III, which is reacted with a compound shown by the formula IV (X is halogen, Br is benzyl; MCA is monochloroacetyl) in a solvent such as 1,2-dichloroethane, etc. in the presence of glycosidation catalyst such as Hg(CH)
      2 , etc. at -20W150°C for 1W120hr, and if necessary, the protecting group is removed, or reduced, to give a compound shown by the formula I .
      COPYRIGHT: (C)1985,JPO&Japio
    • 新材料:由式I表示的化合物(R1为H或CH3; R2为酰基或正丙基; R3和R4为H,D-吡喃葡萄糖基,2,3,4-三-O-苄基-D - 吡喃葡萄糖基,2,3,4-三-O-苄基-6-O-单氯乙酰基-D-吡喃葡萄糖基,苯甲酰基或苄基; R5和R6连接形成异亚丙基或亚苄基; Ac是乙酰基。 使用:脑膜炎的补救措施。 制备:式II化合物脱乙酰化,与2,2-二甲氧基丙烷反应,得到式III所示的新化合物,其与式IV化合物(X为卤素,Br为苄基; MCA 是一氯乙酰基)在溶剂如1,2-二氯乙烷等中,在糖化催化剂如Hg(CH)2等存在下,在-20-150℃下反应1-120小时,如果需要, 除去或还原保护基,得到式I所示的化合物。